AmbAgon Therapeutics Funding & Investors

San Francisco, CA

AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.

Total Amount Raised: $148,000,000

AmbAgon Therapeutics Funding Rounds

Series Unknown
$44,999,996
May 26, 2022
Series A
$85,000,000
Jan 5, 2022
Series A Investors
Nextech Invest
AbbVie
Droia Ventures
INKEF Capital
MRL Ventures Fund
Surveyor Capital
Ra Capital Management
Mission BioCapital
Seed
$18,000,000
Jul 28, 2020

Funding info provided by Diffbot.